SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-068101
Filing Date
2013-09-05
Accepted
2013-09-05 08:00:44
Documents
12
Period of Report
2013-09-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-20084_38k.htm 8-K 24317
2 EX-99.1 a13-20084_3ex99d1.htm EX-99.1 19602
3 GRAPHIC g200843mmi001.jpg GRAPHIC 58657
4 GRAPHIC g200843mmi002.gif GRAPHIC 177359
5 GRAPHIC g200843mmi003.jpg GRAPHIC 73489
6 GRAPHIC g200843mmi004.jpg GRAPHIC 66551
7 GRAPHIC g200843mmi005.gif GRAPHIC 95229
8 GRAPHIC g200843mmi006.gif GRAPHIC 90427
9 GRAPHIC g200843mmi007.jpg GRAPHIC 78419
10 GRAPHIC g200843mmi008.gif GRAPHIC 90410
11 GRAPHIC g200843mmi009.gif GRAPHIC 80772
12 GRAPHIC g200843mmi010.jpg GRAPHIC 52595
  Complete submission text file 0001104659-13-068101.txt   1236860
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 131079252
SIC: 2834 Pharmaceutical Preparations